Penbrook Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,000
Closed -$652 104
2023
Q3
$652 Hold
4,000
﹤0.01% 100
2023
Q2
$733 Buy
+4,000
New +$576K ﹤0.01% 99

Other funds holding ACLS

Penbrook Management's ACLS Position: Q2 2026 in Review

Penbrook Management reduced its Axcelis (ACLS) stake by 9.9% in Q2 2026, selling an estimated $178K and leaving 10,895 shares worth $2.06M. The position accounts for 1.32% of the portfolio, ranked #21.

Penbrook Management first reported a position in ACLS in Q4 2013 and has held it in 47 quarters since. The position peaked at $8.18M in Q2 2023. 133 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Penbrook Management held 10,895 shares of Axcelis worth $2.06M as of Q2 2026.
  • Penbrook Management sold 1,200 Axcelis shares in Q2 2026, an estimated $178K.
  • Axcelis made up 1.32% of Penbrook Management's portfolio in Q2 2026, its #21 holding.
  • Penbrook Management first reported a position in Axcelis in Q4 2013 and has held it in 47 quarters since.
  • Penbrook Management's Axcelis position peaked at $8.18M in Q2 2023.
  • 133 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.